| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 848 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 485 | 2022 |
| Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: an insight from structural data A Khan, T Zia, M Suleman, T Khan, SS Ali, AA Abbasi, A Mohammad, ... Journal of cellular physiology 236 (10), 7045-7057, 2021 | 346 | 2021 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 203 | 2023 |
| Inferences of biogeographical histories within subfamily Hyacinthoideae using S-DIVA and Bayesian binary MCMC analysis implemented in RASP (Reconstruct Ancestral State in … SS Ali, Y Yu, M Pfosser, W Wetschnig Annals of Botany 109 (1), 95-107, 2012 | 131 | 2012 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 127 | 2022 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 111 | 2024 |
| Correlation of different spectral lights with biomass accumulation and production of antioxidant secondary metabolites in callus cultures of medicinally important Prunella … H Fazal, BH Abbasi, N Ahmad, SS Ali, F Akbar, F Kanwal Journal of Photochemistry and Photobiology B: Biology 159, 1-7, 2016 | 111 | 2016 |
| In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro) A Khan, W Heng, Y Wang, J Qiu, X Wei, S Peng, S Saleem, M Khan, ... Phytotherapy research: PTR, 2021 | 106 | 2021 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 102 | 2024 |
| Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro) A Khan, SS Ali, MT Khan, S Saleem, A Ali, M Suleman, Z Babar, A Shafiq, ... Journal of Biomolecular Structure and Dynamics 39 (13), 4659-4670, 2021 | 100 | 2021 |
| Immunoinformatics and structural vaccinology driven prediction of multi-epitope vaccine against Mayaro virus and validation through in-silico expression S Khan, A Khan, AU Rehman, I Ahmad, S Ullah, AA Khan, SS Ali, ... Infection, Genetics and Evolution 73, 390-400, 2019 | 99 | 2019 |
| Phylogenetic analysis and structural perspectives of RNA-dependent RNA-polymerase inhibition from SARs-CoV-2 with natural products A Khan, M Khan, S Saleem, Z Babar, A Ali, AA Khan, Z Sardar, ... Interdisciplinary Sciences: Computational Life Sciences 12, 335-348, 2020 | 96 | 2020 |
| Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein A Khan, MT Khan, S Saleem, M Junaid, A Ali, SS Ali, M Khan, DQ Wei Computational and structural biotechnology journal 18, 2174-2184, 2020 | 93 | 2020 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 90 | 2024 |
| Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems … A Khan, M Junaid, AC Kaushik, A Ali, SS Ali, A Mehmood, DQ Wei PloS one 13 (5), e0196484, 2018 | 90 | 2018 |
| The Omicron (B. 1.1. 529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data A Khan, H Waris, M Rafique, M Suleman, A Mohammad, SS Ali, T Khan, ... International journal of biological macromolecules 200, 438-448, 2022 | 75 | 2022 |
| Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune … A Khan, S Khan, S Saleem, N Nizam-Uddin, A Mohammad, T Khan, ... Computers in Biology and Medicine 133, 104420, 2021 | 74 | 2021 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 72 | 2024 |
| Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein–Barr virus (EBV) A Ali, A Khan, AC Kaushik, Y Wang, SS Ali, M Junaid, S Saleem, ... Scientific reports 9 (1), 720, 2019 | 68 | 2019 |
Abbas KhanShanghai Jiao Tong UniversityVerified email at sjtu.edu.cn
